Full text loading...
, Marta Cortón3,4
, Brenda Martínez-González1
, Rebeca Lobo-Vega1
, Lucía Vázquez-Sirvent1
, Rosario López-Rodríguez3,4, Berta Almoguera3,4, Ignacio Mahillo5, Pablo Mínguez3,4
, Antonio Herrero6, Juan Carlos Taracido6, Alicia Macías-Valcayo1
, Jaime Esteban1
, Ricardo Fernandez-Roblas1, Ignacio Gadea1
, Javier Ruíz-Hornillos7,8,9, Carmen Ayuso3,4
and Celia Perales1,2,10
COVID-19 severity and progression are determined by several host and virological factors that may influence the final outcome of SARS-CoV-2-infected patients. The objective of this work was to determine a possible association between viral load, obtained from nasopharyngeal swabs, and the severity of the infection in a cohort of 448 SARS-CoV-2-infected patients from a hospital in Madrid during the first outbreak of the pandemic in Spain. To perform this, we clinically classified patients as mild, moderate and severe COVID-19 according to a number of clinical parameters such as hospitalization requirement, need of oxygen therapy, admission to intensive care units and/or death. Also, Ct values were determined using SARS-CoV-2-specific oligonucleotides directed to ORF1ab. Here we report a statistically significant association between viral load and disease severity, a high viral load being associated with worse clinical prognosis, independently of several previously identified risk factors such as age, sex, hypertension, cardiovascular disease, diabetes, obesity and lung disease (asthma and chronic obstructive pulmonary disease). The data presented here reinforce viral load as a potential biomarker for predicting disease severity in SARS-CoV-2-infected patients. It is also an important parameter in viral evolution since it relates to the numbers and types of variant genomes present in a viral population, a potential determinant of disease progression.
Article metrics loading...
Full text loading...
References
Data & Media loading...